Bayer and TKMS Stocks Jump on Legal Wins and Technical Gains

Bayer’s share price has more than doubled over the past year, reaching €53.04 and posting a 103 % gain, but technical analysis shows overbought conditions (RSI 85.1) and high volatility, suggesting potential short‑term profit‑taking. The company is also facing several legal developments: the U.S. Supreme Court ruled against Roundup plaintiff John Durnell, limiting similar cancer‑risk claims, and a Missouri court has postponed the hearing on the $7.25 billion Roundup settlement to 19 August, with about 65,000 lawsuits still pending. Additionally, Bayer has filed an anti‑dumping petition with the U.S. Trade Commission seeking duties on Chinese glyphosate imports.

Meanwhile, shares of German defence contractor TKMS rose sharply, gaining about 11 % in a single session and 36 % over four weeks to €93.30. Technical indicators are broadly bullish: the RSI sits at 67 in a neutral zone, the MACD shows a bullish crossover, and the stock is holding above a support range of €87.60‑90.40, with the next resistance level ahead. Analysts note that a break above €103 could unlock further upside for the company, a leading European supplier of naval systems.